Mydecine Innovations Group Management
Management criteria checks 3/4
Mydecine Innovations Group's CEO is Josh Bartch, appointed in Jul 2018, has a tenure of 5.75 years. total yearly compensation is CA$444.52K, comprised of 86.2% salary and 13.8% bonuses, including company stock and options. directly owns 0.61% of the company’s shares, worth CA$11.35K. The average tenure of the management team and the board of directors is 3.5 years and 3.8 years respectively.
Key information
Josh Bartch
Chief executive officer
CA$444.5k
Total compensation
CEO salary percentage | 86.2% |
CEO tenure | 5.8yrs |
CEO ownership | 0.6% |
Management average tenure | 3.5yrs |
Board average tenure | 3.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -CA$18m |
Jun 30 2023 | n/a | n/a | -CA$20m |
Mar 31 2023 | n/a | n/a | -CA$19m |
Dec 31 2022 | CA$445k | CA$383k | -CA$17m |
Sep 30 2022 | n/a | n/a | -CA$23m |
Jun 30 2022 | n/a | n/a | -CA$18m |
Mar 31 2022 | n/a | n/a | -CA$24m |
Dec 31 2021 | CA$2m | CA$346k | -CA$24m |
Sep 30 2021 | n/a | n/a | -CA$19m |
Jun 30 2021 | n/a | n/a | -CA$37m |
Mar 31 2021 | n/a | n/a | -CA$32m |
Dec 31 2020 | CA$819k | CA$153k | -CA$27m |
Sep 30 2020 | n/a | n/a | -CA$39m |
Jun 30 2020 | n/a | n/a | -CA$23m |
Mar 31 2020 | n/a | n/a | -CA$20m |
Dec 31 2019 | CA$238k | CA$238k | -CA$21m |
Sep 30 2019 | n/a | n/a | -CA$5m |
Jun 30 2019 | n/a | n/a | -CA$5m |
Mar 31 2019 | n/a | n/a | -CA$11m |
Dec 31 2018 | CA$425k | CA$302k | -CA$13m |
Compensation vs Market: Josh's total compensation ($USD325.35K) is above average for companies of similar size in the Canadian market ($USD175.11K).
Compensation vs Earnings: Josh's compensation has been consistent with company performance over the past year.
CEO
Josh Bartch (35 yo)
5.8yrs
Tenure
CA$444,518
Compensation
Mr. David Joshua Bartch, also known as Josh, serves as Chairman of the Board at Mydecine Innovations Group Inc. Mr. Bartch is Co-Founder of Mydecine Innovations Group Inc. and serves as its President, Chie...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 5.8yrs | CA$444.52k | 0.61% CA$ 11.3k | |
Co-Founder | 3.9yrs | CA$455.31k | 0.21% CA$ 3.8k | |
Co-Founder & COO | 3.9yrs | CA$455.31k | 0.15% CA$ 2.7k | |
CFO & Corporate Secretary | 1.6yrs | CA$9.20k | no data | |
Chief Compliance Officer & General Counsel | 3.5yrs | CA$317.36k | no data | |
Chief Medical Officer | 3.4yrs | CA$271.20k | no data | |
Director of Marketing | no data | no data | no data | |
President of the European Operations | 3.1yrs | no data | no data | |
Interim CEO & Technical Director of Mindleap Health Inc. | 2.9yrs | no data | no data |
3.5yrs
Average Tenure
Experienced Management: MYCO's management team is considered experienced (3.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 5.8yrs | CA$444.52k | 0.61% CA$ 11.3k | |
Co-Founder | 3.3yrs | CA$455.31k | 0.21% CA$ 3.8k | |
Member of Medical | 3.8yrs | no data | no data | |
Member of Medical | 3.8yrs | no data | no data | |
Member of Medical | 3.8yrs | no data | no data | |
Member of Medical | no data | no data | no data | |
Member of Medical | no data | no data | no data | |
Member of Medical | no data | no data | no data | |
Member of Medical | no data | no data | no data | |
Member of Medical | no data | no data | no data | |
Member of Medical | 3.7yrs | no data | no data | |
Member of Medical | 3.7yrs | no data | no data |
3.8yrs
Average Tenure
Experienced Board: MYCO's board of directors are considered experienced (3.8 years average tenure).